Blockchain Registration Transaction Record

Hospital CEOs Pocket 340B Funds Meant for Poor Patients

ADAP Advocacy reveals hospital CEOs are using 340B Drug Pricing Program funds for excessive compensation instead of patient care. New infographics show $66B program misuse.

This investigation matters because it exposes how a critical healthcare safety net program designed to help low-income patients access medications is being exploited to enrich hospital executives instead. The 340B Drug Pricing Program was created to stretch scarce federal resources further, allowing safety-net hospitals and clinics to provide more comprehensive care to vulnerable populations. When these funds are diverted to executive compensation rather than patient services, it undermines the entire purpose of the program and potentially limits healthcare access for those who need it most. This affects every taxpayer and healthcare consumer, as it represents a misuse of public health resources that could drive up overall healthcare costs while reducing care quality for society's most vulnerable members.